ST-603

ST-603 is a small molecule inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3) protein, which is frequently overexpressed or constitutively active in various human cancers. By targeting the SH2 domain of STAT3, ST-603 prevents the dimerization, nuclear translocation, and DNA binding of the protein, thereby inhibiting the transcription of genes involved in cell proliferation, survival, and angiogenesis. The drug has been investigated primarily for its potential in treating solid tumors and hematological malignancies where STAT3 signaling plays a critical role in oncogenesis and immune evasion. Preclinical studies have demonstrated its ability to induce apoptosis in cancer cells and enhance the efficacy of other chemotherapeutic agents.